InflaRx N.V.
NASDAQ:IFRXBiotechnology
Healthcare
$1.09 -0.82%
-$0.02 today
- Market cap
- $160.63M
- Beta
- 2.44
- P/E (TTM)
- -2.7
- EPS (TTM)
- -$0.59
52W Low $0.74High $2.95
Volume 0.66M
Average 1.80M
Balance Sheet
Inspect the capital base behind the business.
Assets
$55.19M
FY 2025 · Annual
-27.4% YoYLiabilities
$13.65M
FY 2025 · Annual
-6.5% YoYEquity
$41.54M
FY 2025 · Annual
-32.4% YoYBalance Sheet
EUR
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 26.25M | 16.27M | 12.77M | 18.38M | 16.02M |
| Short-term Investments | 57.16M | 65.54M | 0 | 0 | 30.42M |
| Net Receivables | 1.28M | 1.43M | 0 | 0 | 1.43M |
| Inventory | 0 | 0 | 11.37M | 6.9M | 0 |
| Other Current Assets | 0 | 2.55M | 85.06M | 46.03M | 5.75M |
| Total Current Assets | 95.68M | 97.41M | 109.47M | 71.66M | 53.61M |
| Property, Plant & Equipment (Net) | 1.68M | 1.64M | 1.36M | 1.01M | 1.15M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 235.22K | 138.91K | 42.84K | 7.26K | 42.24K |
| Long-term Investments | 27.21M | 2.9M | 9.05M | 3.09M | 237.27K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 336.57K | 308.07K | 283.25K | 247.75K | 151.14K |
| Total Non-current Assets | 29.46M | 4.99M | 10.74M | 4.36M | 1.58M |
| Total Assets | 125.14M | 102.4M | 120.21M | 76.02M | 55.19M |
| Account Payables | 1.69M | 4.99M | 5.1M | 3.41M | 5.4M |
| Short-term Debt | 0 | 0 | 0 | 0 | 256.83K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 8.3M | 6.21M | 0 | 0 | 0 |
| Other Current Liabilities | 1.52M | (1.96M) | 2.89M | 301.54K | 6.16M |
| Total Current Liabilities | 18.76M | 13.03M | 16.84M | 14.17M | 12.98M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 35.02K | 36.88K | 36.88K | 36.88K | 36.86K |
| Total Non-current Liabilities | 1.1M | 1.02M | 782.59K | 435.94K | 677.56K |
| Total Liabilities | 19.86M | 14.05M | 17.63M | 14.6M | 13.65M |
| Common Stock | 5.3M | 5.36M | 7.07M | 7.12M | 8.67M |
| Retained Earnings | (213.98M) | (243.46M) | (286.13M) | (332.19M) | (377.67M) |
| Accumulated OCI | 30.59M | 36.64M | 47.43M | 51.56M | 48.54M |
| Other Stockholders Equity | 3.05M | 7.26M | 1 | 0 | 7.17M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 105.28M | 88.35M | 102.58M | 61.42M | 41.54M |
| Total Debt | 1.43M | 1.36M | 1.12M | 805.09K | 897.53K |
| Net Debt | (24.82M) | (14.91M) | (11.65M) | (17.57M) | (15.12M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $15.0M |
| Short-term Investments | $24.8M |
| Receivables | $1.7M |
| Other Current | $6.0M |
| Total Current Assets | $47.4M |
| PP&E (Net) | $1.1M |
| Intangible Assets | $45.6K |
| Long-term Investments | $237.7K |
| Other Non-current | $139.3K |
| Total Non-current Assets | $1.5M |
| Total Assets | $48.9M |
Analysis
Selected assets total $48.9M for Latest. The largest visible component is Short-term Investments at $24.8M, about 50.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 6, 2026 | |
| 6-K | 6-K filing | Nov 3, 2026 | |
| 6-K | 6-K filing | Nov 3, 2026 | |
| 6-K | 6-K filing | Oct 22, 2026 | |
| SC 13G | SC 13G filing | Aug 17, 2026 |
How much cash does IFRX have?
InflaRx N.V. (IFRX) reported $16.02M in cash and equivalents in fiscal 2025.
How much debt does IFRX carry?
InflaRx N.V. (IFRX) reported $897,532.00 of total debt, with net debt of -$15.12M.
Continue the stock analysis
Jump to another research area for this company.